Fenn C. Mathew

Array ( [id] => 4277256 [patent_doc_number] => 06281207 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Treatment of movement disorders by administration of mirtazapine' [patent_app_type] => 1 [patent_app_number] => 9/396335 [patent_app_country] => US [patent_app_date] => 1999-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5871 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281207.pdf [firstpage_image] =>[orig_patent_app_number] => 396335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4249409 [patent_doc_number] => 06221887 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Treatment of inflammatory disorders with NMDA antagonists and sodium channel antagonists' [patent_app_type] => 1 [patent_app_number] => 9/380988 [patent_app_country] => US [patent_app_date] => 1999-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1292 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221887.pdf [firstpage_image] =>[orig_patent_app_number] => 380988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4327422 [patent_doc_number] => 06329414 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Histidine containing nutriceutical' [patent_app_type] => 1 [patent_app_number] => 9/393891 [patent_app_country] => US [patent_app_date] => 1999-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9480 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329414.pdf [firstpage_image] =>[orig_patent_app_number] => 393891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4184283 [patent_doc_number] => 06150353 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders' [patent_app_type] => 1 [patent_app_number] => 9/380723 [patent_app_country] => US [patent_app_date] => 1999-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2396 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150353.pdf [firstpage_image] =>[orig_patent_app_number] => 380723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521054 [patent_doc_number] => 06413961 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Irrigation solution and method for inhibition of pain and inflammation' [patent_app_type] => B1 [patent_app_number] => 09/388837 [patent_app_country] => US [patent_app_date] => 1999-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 28164 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413961.pdf [firstpage_image] =>[orig_patent_app_number] => 09388837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320429 [patent_doc_number] => 06248745 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Pharmaceutical combination comprising a COX-2 inhibitor and a iNOS inhibitor' [patent_app_type] => 1 [patent_app_number] => 9/380379 [patent_app_country] => US [patent_app_date] => 1999-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4450 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 739 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248745.pdf [firstpage_image] =>[orig_patent_app_number] => 380379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533123 [patent_doc_number] => 06410540 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Inhibitors of p38-kinase' [patent_app_type] => B1 [patent_app_number] => 09/385494 [patent_app_country] => US [patent_app_date] => 1999-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8533 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410540.pdf [firstpage_image] =>[orig_patent_app_number] => 09385494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521057 [patent_doc_number] => 06413962 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Guanidino compounds effective as anesthetics' [patent_app_type] => B1 [patent_app_number] => 09/377878 [patent_app_country] => US [patent_app_date] => 1999-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19138 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413962.pdf [firstpage_image] =>[orig_patent_app_number] => 09377878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7001098 [patent_doc_number] => 20010053797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-20 [patent_title] => 'MODULATION OF N-METHYL-D-ASPARTATE RECEPTOR RESPONSES WITH S-SUBSTITUTED DERIVATIVES OF GLUTATHIONE' [patent_app_type] => new [patent_app_number] => 09/376530 [patent_app_country] => US [patent_app_date] => 1999-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6121 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20010053797.pdf [firstpage_image] =>[orig_patent_app_number] => 09376530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4346331 [patent_doc_number] => 06284757 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Pyrrolo[1,2-a]pyrazine derivatives as 5HT1A ligands' [patent_app_type] => 1 [patent_app_number] => 9/372438 [patent_app_country] => US [patent_app_date] => 1999-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14970 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 268 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284757.pdf [firstpage_image] =>[orig_patent_app_number] => 372438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4323573 [patent_doc_number] => 06331571 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Methods of treating and preventing attention deficit disorders' [patent_app_type] => 1 [patent_app_number] => 9/372158 [patent_app_country] => US [patent_app_date] => 1999-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16628 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331571.pdf [firstpage_image] =>[orig_patent_app_number] => 372158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406945 [patent_doc_number] => 06232311 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Method for treating or preventing psychosomatic and psychoimmunologic disorders' [patent_app_type] => 1 [patent_app_number] => 9/371394 [patent_app_country] => US [patent_app_date] => 1999-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18316 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232311.pdf [firstpage_image] =>[orig_patent_app_number] => 371394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296183 [patent_doc_number] => 06184236 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative' [patent_app_type] => 1 [patent_app_number] => 9/370602 [patent_app_country] => US [patent_app_date] => 1999-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16005 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184236.pdf [firstpage_image] =>[orig_patent_app_number] => 370602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409855 [patent_doc_number] => 06300332 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Methods for reducing respiratory depression and attendant side effects of mu opioid compounds' [patent_app_type] => 1 [patent_app_number] => 9/352308 [patent_app_country] => US [patent_app_date] => 1999-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21161 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300332.pdf [firstpage_image] =>[orig_patent_app_number] => 352308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360375 [patent_doc_number] => 06169098 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Composition and methods employing it for the treatment of 5-HT-mediated disorders' [patent_app_type] => 1 [patent_app_number] => 9/351069 [patent_app_country] => US [patent_app_date] => 1999-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2263 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/169/06169098.pdf [firstpage_image] =>[orig_patent_app_number] => 351069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383878 [patent_doc_number] => 06262081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Composition for and method of treating neurological disorders' [patent_app_type] => 1 [patent_app_number] => 9/349906 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6409 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262081.pdf [firstpage_image] =>[orig_patent_app_number] => 349906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410762 [patent_doc_number] => 06228888 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/345782 [patent_app_country] => US [patent_app_date] => 1999-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14776 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228888.pdf [firstpage_image] =>[orig_patent_app_number] => 345782 [rel_patent_id] =>[rel_patent_doc_number] =>)